抗性高血压的发病和治疗方面的进展
Jill Dybiec1, Julia Krzemińska1, Ewa Radzioch1
1Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Łódź, Poland.
International journal of molecular sciences
|August 26, 2023
概括
抗性高血压 (RH) 影响6-18%的高血压患者,增加心血管风险. 本综述探讨了RH的原因,诊断和创新的治疗方法,如脏化,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 高血压研究 高血压研究
背景情况:
- 高血压是导致心血管疾病过早死亡的主要危险因素.
- 耐性高血压 (RH) 是一种严重的高血压形式,患病率不清楚 (6-18%).
- 了解RH病原和治疗对于患者管理至关重要.
研究的目的:
- 审查抗高血压治疗中治疗耐药性的原因.
- 突出诊断方法来识别耐药高血压.
- 讨论用于管理RH的创新性和侵入性疗法.
主要方法:
- 文献综述专注于抗性高血压.
- 对治疗耐药性的诊断方法的分析.
- 评估新的治疗策略,包括神经调节和外科手术.
主要成果:
- 耐药高血压的患病率在不同人群中存在显著差异.
- 识别治疗耐药性的原因是有效管理的关键.
- 自主神经调节 (例如,脏缩) 和动脉静脉解剖显示出有希望的结果.
结论:
- 准确的诊断和理解RH是必不可少的.
- 创新疗法为耐性高血压患者提供了新的希望.
- 对病原和治疗优化的进一步研究是有必要的.
相关概念视频
Hypertension II: Pathophysiology
15
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
15
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Hypertension IV: Drug Therapy and Lifestyle Modifications
14
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
14
Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Antihypertensive Drugs: Direct Renin Inhibitors
680
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
680
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K


